Acrycoat E 100-40 represents a premium pharmaceutical-grade polymer solution specifically engineered as a 40% concentration in Isopropanol. This advanced basic butylated methacryla...
Acrycoat E 100-40 represents a premium pharmaceutical-grade polymer solution specifically engineered as a 40% concentration in Isopropanol. This advanced basic butylated methacrylate copolymer strictly conforms to European Pharmacopoeia specifications, delivering exceptional film-forming capabilities for precise drug delivery applications. The light yellow liquid formulation provides reliable gastric-soluble coatings that remain insoluble at neutral pH levels while becoming readily soluble in acidic gastric environments. Manufactured under stringent quality controls, this polymer ensures consistent performance where exact drug release profiles and product stability are paramount. Its balanced viscosity and application properties make it suitable for various coating processes, from standard tablet coating to specialized drug delivery systems.
This versatile polymer solution finds extensive application across pharmaceutical manufacturing, particularly in enteric-coated tablets, capsules, and advanced drug delivery platforms. Nutraceutical producers utilize it to protect sensitive nutritional compounds from gastric degradation while ensuring optimal absorption. Veterinary pharmaceutical companies incorporate it into animal health products requiring precise release mechanisms in digestive systems. Transdermal therapy system manufacturers value its functional properties for creating effective drug delivery patches with controlled release profiles. Medical device companies also employ it for coating implantable devices where sustained drug elution is necessary for therapeutic effectiveness.
The business value of Acrycoat E 100-40 lies in its proven reliability and consistent quality that reduces manufacturing variability and compliance risks. Its compliance with international pharmacopeia standards streamlines regulatory approvals and enhances product acceptance across global markets. The formulation's efficiency ensures optimal coverage with minimal material waste, contributing to lower production costs and improved manufacturing economics. Manufacturers benefit from enhanced finished product stability and extended shelf life, while the dependable supply chain ensures production continuity. The product's technical support infrastructure provides additional value through application guidance and troubleshooting assistance.
Key Features:
- 40% solution in Isopropanol with consistent viscosity and reliable performance
- Conforms to European Pharmacopoeia specifications for basic butylated methacrylate copolymer
- Light yellow liquid formulation enabling easy visual inspection during application
- Creates protective films insoluble at neutral pH and soluble in acidic gastric environments
- Customizable concentration and properties to meet specific manufacturing requirements
Benefits:
- Ensures precise drug release profiles through reliable gastric-soluble coating performance
- Reduces regulatory compliance risks with adherence to international pharmacopeia standards
- Enhances manufacturing efficiency with consistent viscosity and easy application properties
- Protects sensitive active ingredients from degradation while enabling targeted delivery
- Provides formulation flexibility for various pharmaceutical and therapeutic applications